Cyclosporine Ophthalmic Suspension [Verkazia]
RxNorm 2590612
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2590612 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: cyclosporine Ophthalmic Suspension [Verkazia].
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDFPrescribable
Semantic Branded Drug Form (SBDF):
Cyclosporine Ophthalmic Suspension [Verkazia]
(Atom ID: 12722260)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
CycloSPORINE Ophthalmic Suspension [Verkazia]
(Atom ID: 12723375)
Patient Education
Cyclosporine Ophthalmic
Ophthalmic cyclosporine is used to increase tear production in people with dry eye disease. Cyclosporine is in a class of medications called immunomodulators. It works by decreasing swelling in the eye to allow for tear production.
[Learn More]
* Please review the disclaimer below.